CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 109 filers reported holding CYTEK BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,777,379 | -28.3% | 321,992 | +10.9% | 0.00% | -33.3% |
Q2 2023 | $2,480,203 | +180541.2% | 290,422 | +94.4% | 0.00% | +50.0% |
Q1 2023 | $1,373 | -5.7% | 149,367 | +4.8% | 0.00% | 0.0% |
Q4 2022 | $1,456 | -99.9% | 142,563 | +1.3% | 0.00% | -33.3% |
Q3 2022 | $2,071,000 | +49.6% | 140,718 | +9.1% | 0.00% | +50.0% |
Q2 2022 | $1,384,000 | +33.3% | 128,967 | +34.0% | 0.00% | +100.0% |
Q1 2022 | $1,038,000 | +328.9% | 96,278 | +549.5% | 0.00% | – |
Q4 2021 | $242,000 | -4.0% | 14,823 | +26.0% | 0.00% | – |
Q3 2021 | $252,000 | – | 11,761 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
Miura Global Management | 820,000 | $12,070,000 | 7.24% |
RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
Parkwood LLC | 42,336 | $623,000 | 0.09% |
PDT Partners, LLC | 31,436 | $463,000 | 0.07% |